Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients.
Colak
T
T
Baskent University Faculty of Medicine, Ankara, Turkey.
Karakayali
H
H
Yagmurdur
M C
MC
Moray
G
G
D000328:Adult; D002784:Cholesterol / Q000097:blood*; D016572:Cyclosporine / Q000009:adverse effects*; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced / Q000517:prevention & control; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D016559:Tacrolimus / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood*
D007166:Immunosuppressive Agents; D014280:Triglycerides; D016572:Cyclosporine; D002784:Cholesterol; D016559:Tacrolimus